Ingrid E. Wertz
Impact in
- Cancer Research top 0.5%
- NF-κB Signaling Pathways
- Immunology top 1%
- interferon and immune responses
- Immune Response and Inflammation
Papers in
-
- NF-κB Signaling Pathways 14
-
- Ubiquitin and proteasome pathways 37
- Protein Degradation and Inhibitors 16
- Cell death mechanisms and regulation 6
- Co-authors
- Vishva M. Dixit (14 shared papers)Karen M. O’Rourke (4 shared papers)Honglin Zhou (3 shared papers)Domagoj Vucic (3 shared papers)Michael T. Eby (2 shared papers)Somasekar Seshagiri (2 shared papers)S.G. Hymowitz (3 shared papers)David P. Arnott (5 shared papers)
- Journals
- Nature (7 papers)Cell (3 papers)Molecular Cell (3 papers)Journal of the American Chemical Society (2 papers)Nature Immunology (2 papers)
- Partner nations
- United StatesAustraliaChina
In The Last Decade
Ingrid E. Wertz
58 papers receiving 9.1k citations
Ingrid E. Wertz's Hit Papers
Peers
Comparison fields: 5 of 129
- Cancer Research 2.3k
- Immunology 2.4k
- Oncology 2.6k
- Molecular Biology 6.5k
- Cell Biology 689
Countries citing papers authored by Ingrid E. Wertz
This map shows the geographic impact of Ingrid E. Wertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid E. Wertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid E. Wertz more than expected).
Fields of papers citing papers by Ingrid E. Wertz
This network shows the impact of papers produced by Ingrid E. Wertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid E. Wertz. The network helps show where Ingrid E. Wertz may publish in the future.
Co-authors
The 25 scholars most cited alongside Ingrid E. Wertz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling Hit paper breakdown → | 2004 | 1615 |
| 2 | Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7 Hit paper breakdown → | 2011 | 662 |
| 3 | 2004 | 581 | |
| 4 | 2015 | 500 | |
| 5 | 2008 | 485 | |
| 6 | 2003 | 445 | |
| 7 | 2015 | 386 | |
| 8 | Ubiquitination in the regulation of inflammatory cell death and cancer Hit paper breakdown → | 2021 | 383 |
| 9 | 2011 | 367 | |
| 10 | 2004 | 310 | |
| 11 | 2017 | 278 | |
| 12 | 2010 | 219 | |
| 13 | 2015 | 217 | |
| 14 | 2005 | 190 | |
| 15 | 2010 | 163 | |
| 16 | 2019 | 156 | |
| 17 | 2011 | 144 | |
| 18 | 2022 | 140 | |
| 19 | 1996 | 133 | |
| 20 | 2018 | 132 |
About Ingrid E. Wertz
Ingrid E. Wertz is a scholar working on Cancer Research, Molecular Biology, Oncology, Immunology and Epidemiology, having authored 59 papers that have together received 9.4k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (37 papers), Protein Degradation and Inhibitors (16 papers), NF-κB Signaling Pathways (14 papers), interferon and immune responses (11 papers), Cancer-related Molecular Pathways (10 papers), Peptidase Inhibition and Analysis (8 papers), Autophagy in Disease and Therapy (7 papers) and Cell death mechanisms and regulation (6 papers). The work is most often cited by research in Cancer Research (2.3k citations), Immunology (2.4k citations), Oncology (2.6k citations), Molecular Biology (6.5k citations) and Cell Biology (689 citations). Ingrid E. Wertz has collaborated with scholars based in United States, Australia and China. Frequent co-authors include Vishva M. Dixit, Karen M. O’Rourke, Honglin Zhou, Domagoj Vucic, Michael T. Eby, Somasekar Seshagiri, S.G. Hymowitz, David P. Arnott, Averil Ma and Eugene V. Koonin. Their work appears in journals such as Nature, Cell, Molecular Cell, Journal of the American Chemical Society and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.